Search results: Sage Journals

Available accessReview articleFirst published September, 2022

Management of Myeloproliferative Neoplasms (MPNs)

Zubeir Nurgat, Myer Lawrence

Journal of Oncology Pharmacy Practice

Open accessCase reportFirst published 2026

A Hidden Driver Mutation in Myeloproliferative Neoplasms: SH2B3 and Diagnostic Implications and Response to Ropeginterferon Alfa-2b

Karina Basmajian, Lauren Rachel Chang Borecky, Mojtaba Akhtari

Journal of Investigative Medicine High Impact Case Reports

Open accessResearch articleFirst published 2026

Heterogeneity among patients with myeloproliferative neoplasms: Identifying distinct profiles through cluster analysis

Annemiek A. M. Eppingbroek, Lilian Lechner, Moniek A. de Witte [...]

Journal of Health Psychology

Open accessResearch articleFirst published 2022

Association Between Cancer-Related Fatigue and Falls in Patients With Myeloproliferative Neoplasms: Results of a Multicenter Cross-Sectional Survey From the East German Study Group for Hematology and Oncology (OSHO #97)

Sabine Felser, Martin Gube, Julia Gruen [...]

Integrative Cancer Therapies

Open accessResearch articleFirst published 2026

PD-1/PD-L1-CXCR3 Coexpression and CXCR3 on Intermediate Monocytes Predict Fibrosis,Leukemic Transformation,and Survival in Egyptian Philadelphia-Negative Myeloproliferative Neoplasms

Dalia E Sherief, Rawan Ahmed Elmezien, Nahla Nosair [...]

Clinical Medicine Insights: Oncology

Open accessBrief reportFirst published 2026

Ruxolitinib treatment in patients with polycythemia vera reduces JAK2 variant allele frequency and improves symptom burden and hematocrit control

Claire N. Harrison, Jean-Jacques Kiladjian, J. E. Hamer-Maansson [...]

Therapeutic Advances in Hematology

Open accessCase reportFirst published May, 2021

Development of a myelodysplastic/myeloproliferative neoplasm-unclassifiable in a patient with acute myeloid leukemia: a case report and literature review

Meifang Zhao, Jingnan Sun, Shanshan Liu [...]

Journal of International Medical Research

Free accessResearch articleFirst published July, 2013

Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation

Tiantian Sun, Lei Zhang

Clinical and Applied Thrombosis/Hemostasis

Free accessReview articleFirst published March, 2017

Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease

Joan How, Amy Zhou, Stephen T. Oh

Therapeutic Advances in Hematology

Open accessReview articleFirst published 2021

Environmental Factors,Lifestyle Risk Factors,and Host Characteristics Associated With Philadelphia Negative Myeloproliferative Neoplasm: A Systematic Review

Niloofar Allahverdi, Mohamed Yassin, Mohamed Ibrahim

Cancer Control

Available accessReview articleFirst published September, 2022

Management of Myeloproliferative Neoplasms (MPNs)

Zubeir Nurgat, Myer Lawrence

Journal of Oncology Pharmacy Practice

Open accessCase reportFirst published 2026

A Hidden Driver Mutation in Myeloproliferative Neoplasms: SH2B3 and Diagnostic Implications and Response to Ropeginterferon Alfa-2b

Karina Basmajian, Lauren Rachel Chang Borecky, Mojtaba Akhtari

Journal of Investigative Medicine High Impact Case Reports

Open accessResearch articleFirst published 2026

Heterogeneity among patients with myeloproliferative neoplasms: Identifying distinct profiles through cluster analysis

Annemiek A. M. Eppingbroek, Lilian Lechner, Moniek A. de Witte [...]

Journal of Health Psychology

Open accessResearch articleFirst published 2022

Association Between Cancer-Related Fatigue and Falls in Patients With Myeloproliferative Neoplasms: Results of a Multicenter Cross-Sectional Survey From the East German Study Group for Hematology and Oncology (OSHO #97)

Sabine Felser, Martin Gube, Julia Gruen [...]

Integrative Cancer Therapies

Open accessResearch articleFirst published 2026

PD-1/PD-L1-CXCR3 Coexpression and CXCR3 on Intermediate Monocytes Predict Fibrosis,Leukemic Transformation,and Survival in Egyptian Philadelphia-Negative Myeloproliferative Neoplasms

Dalia E Sherief, Rawan Ahmed Elmezien, Nahla Nosair [...]

Clinical Medicine Insights: Oncology

Open accessBrief reportFirst published 2026

Ruxolitinib treatment in patients with polycythemia vera reduces JAK2 variant allele frequency and improves symptom burden and hematocrit control

Claire N. Harrison, Jean-Jacques Kiladjian, J. E. Hamer-Maansson [...]

Therapeutic Advances in Hematology

Open accessCase reportFirst published May, 2021

Development of a myelodysplastic/myeloproliferative neoplasm-unclassifiable in a patient with acute myeloid leukemia: a case report and literature review

Meifang Zhao, Jingnan Sun, Shanshan Liu [...]

Journal of International Medical Research

Free accessResearch articleFirst published July, 2013

Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation

Tiantian Sun, Lei Zhang

Clinical and Applied Thrombosis/Hemostasis

Free accessReview articleFirst published March, 2017

Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease

Joan How, Amy Zhou, Stephen T. Oh

Therapeutic Advances in Hematology

Open accessReview articleFirst published 2021

Environmental Factors,Lifestyle Risk Factors,and Host Characteristics Associated With Philadelphia Negative Myeloproliferative Neoplasm: A Systematic Review

Niloofar Allahverdi, Mohamed Yassin, Mohamed Ibrahim

Cancer Control